Stem cells--a hard sell to investors.
Giebel
Lutz B
LB
SV Life Sciences.
D001709:Biotechnology / Q000191:economics*; D006801:Humans; D007449:Investments; D019636:Neurodegenerative Diseases / Q000628:therapy; D033581:Stem Cell Transplantation / Q000191:economics* / Q000941:ethics / Q000331:legislation & jurisprudence; D013234:Stem Cells